Search

everythinglearnresearchcommunity

for

Search:↓

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Nano-quercetin improves quercetin's effectiveness in treating diseases but faces challenges in safety and production.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

Early treatment of Folliculitis Decalvans in children can improve inflammation and partially regrow hair.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

Trichoscopy helps distinguish between scalp Discoid Lupus Erythematosus and Lichen Planopilaris for accurate diagnosis and treatment.

Combination therapy may be more effective for difficult-to-treat scalp conditions.

Microinfusion therapy and testosterone use may cause scalp inflammation, requiring early recognition and treatment.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

New treatments for seborrheic dermatitis show promise for difficult cases.

Periplaneta americana extract helps hair regrowth by reducing inflammation and improving skin bacteria balance.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

The patient improved significantly after treatment, with only one small scar remaining.